Guilford Pharmaceuticals Inc. Invites You to Listen to a Replay of Its Third Quarter Conference Call on the Web

Baltimore (PROTEXT) - In conjunction with GuilfordPharmaceuticals Inc. (Nasdaq: GLFD) Third Quarter earningsrelease, you are invited to listen to a replay of its conferencecall with Dr. Craig Smith, President and CEO of GuilfordPharmaceuticals. The replay will be available on the Internettoday, October 29, 1999. What:

Guilford Pharmaceuticals Third Quarter Earnings

Release When:

Today, Oct. 29 Where:

http://www.videonewswire.com/GUILFORD/102599 How:

Simply log on to the web at the address above and

click investor relations, then third quarter

conference call. Contact:

Stacey Jurchison, (in the USA) 410-631-5022, or

Angela Rubin, (in the USA) 410-631-6449, both

Corporate Communications of GuilfordPharmaceuticals Third Quarter Conference Call Highlights: -- Completion of private financing which raised net proceedsof

approximately $42 million -- Receipt of milestone payments totaling $4.5 million for

approval to market GLIADEL(R) Wafer in France and Germany -- Initiation of Phase I neuroimmunophilin clinical trial in

Europe -- Completion of preclinical testing of PACLIMER(TM) Injection -- Engaged Gynecologic Oncology Group to conduct Phase I/II

clinical trial for PACLIMER(TM) Injection -- Updates on NAALADase and PARP inhibitor research programs Guilford Pharmaceuticals Inc. is a biopharmaceutical companyengaged in the development of polymer-based therapeutics forcancer, and novel products for the diagnosis and treatment ofneurological diseases, including Parkinson's disease, Alzheimer'sdisease, stroke, severe head trauma, spinal cord injuries,multiple sclerosis, and peripheral neuropathies. The call will be archived on the Web sitehttp://www.guilfordpharm.com. To access the replay, click onWhat's New or Investor Relations. The call will also be archivedat www.prnewswire.com. (Minimum Requirements to listen to broadcast: The RealPlayersoftware, downloadable free fromwww.real.com/products/player/index.html, and at least a 14.4Kbpsconnection to the Internet. If you experience problems listeningto the broadcast, send an email to webmaster@vdat.com.) otsOriginal Text Service: Guilford Pharmaceuticals Inc. Internet:http://www.newsaktuell.de Contact: Stacey Jurchison, 410-631-5022, or Angela Rubin, 410-631-6449, both CorporateCommunications of Guilford Pharmaceuticals Company News On-Call:http://www.prnewswire.com/comp/112882.html or fax, 800-758-5804,ext. 112882 Web site: http://www.guilfordpharm.com Audio:http://www.videonewswire.com/GUILFORD/102599

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT